ChartRow logo
Data provided bySource: Twelve Data
PeersNDSNAMEOTISITWDOVGGG
Share this page

IEX financial statements

The full income statement, balance sheet, and cash-flow statement for IDEX Corporation (IEX), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.

Financial overview#

Revenue

5Y CAGR +8.0%10Y CAGR +5.5%YoY +8.3%
$3.7B TTM$951.7M Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Gross profit

5Y CAGR +8.4%10Y CAGR +5.5%YoY +10.0%
$1.6B TTM$429.5M Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Operating income

5Y CAGR +6.1%10Y CAGR +4.8%YoY +11.9%
$763.9M TTM$208M Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Net income

5Y CAGR +5.0%10Y CAGR +5.5%YoY +12.8%
$535.8M TTM$144.1M Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

EPS (diluted)

5Y CAGR +5.3%10Y CAGR +5.9%YoY +14.7%
$7.21 TTM$1.95 Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Operating cash flow

5Y CAGR +3.6%10Y CAGR +6.6%YoY +17.7%
$752.7M TTM$239.5M Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Capital expenditure

5Y CAGR +4.3%10Y CAGR +3.8%YoY +70.3%
$85.6M TTM$25.2M Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Free cash flow

5Y CAGR +3.6%10Y CAGR +6.9%YoY +13.6%
$667.1M TTM$214.3M Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Shares (diluted)

5Y −1.4%10Y −3.4%YoY −1.6%
74.3M TTM74M Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Dividend per share

5Y CAGR +7.3%10Y CAGR +8.3%YoY +2.8%
$2.90 TTM$0.73 Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Every IEX chart on Trends →

Shares outstanding (point-in-time)

2024-09 75.7M2024-12 75.8M2025-03 75.5M2025-06 75.3M2025-09 74.8M2025-12 74.3M2026-03 74.0M2026-06 73.7M2026-09 73.5M-3.0% over 8 periods

SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.

PeriodRangeOrderChangeFiguresAs-reported fiscal years.
Line itemTrendFY2025FY2024FY2023FY2022FY2021
Income Statementas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Revenue3.46B+5.8%3.27B-0.2%3.27B+2.9%3.18B+15.1%2.76B+17.6%
1.54B+6.5%1.45B-0.1%1.45B+1.4%1.43B+16.5%1.22B+19.2%
Cost of revenue1.92B+5.2%1.82B-0.2%1.83B+4.1%1.75B+13.9%1.54B+16.3%
Research & development70.0M+3.9%67.4M-1.5%68.4M+11.4%61.4M+22.6%50.1M+3.9%
Selling, general & administrative819M+7.9%759M+7.8%704M+7.8%653M+12.9%578M+16.8%
Restructuring19.9M+116.3%9.20M-8.9%10.1M+87.0%5.40M-36.5%8.50M-3.4%
Amortization of intangibles131M+22.0%107M+12.9%94.9M+37.5%69.0M+22.3%56.4M+34.9%
Operating income699M+3.3%677M-7.5%733M-2.5%751M+18.0%637M+22.3%
Interest expense——51.7M+27.0%40.7M-0.7%41.0M-8.5%
Other non-operating income-2.30M-188.5%2.60M+150.0%-5.20M-233.3%3.90M+124.1%-16.2M-189.3%
Pre-tax income633M-1.0%639M-15.9%760M+1.5%749M+29.3%580M+23.3%
Income tax150M+11.4%135M-18.2%165M+1.2%163M+24.7%131M+41.1%
483M-4.3%505M-15.3%596M+1.6%587M+30.6%449M+19.0%
Net income to non-controlling interest-700K-75.0%-400K+20.0%-500K-150.0%-200K-100.0%-100K
Net income to common483M-4.3%505M-15.3%596M+1.6%587M+30.6%449M+19.0%
$6.41-3.5%$6.64-15.4%$7.85+1.8%$7.71+31.1%$5.88+19.0%
EPS (basic)$6.41-3.8%$6.66-15.4%$7.87+1.7%$7.74+31.0%$5.91+18.7%
Weighted-avg shares (basic)75.3M-0.5%75.7M+0.1%75.6M-0.1%75.7M-0.4%76.0M+0.4%
Weighted-avg shares (diluted)75.3M-0.8%75.9M+0.0%75.9M-0.1%76.0M-0.5%76.4M+0.0%
Dividends per share$2.84+2.9%$2.76+7.8%$2.56+6.7%$2.40+11.1%$2.16+8.0%
Balance Sheetas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
1.64B+3.2%1.59B+10.1%1.45B+3.4%1.40B-16.6%1.68B+1.3%
Cash & equivalents580M-6.6%621M+16.2%534M+24.2%430M-49.7%855M-16.6%
Accounts receivable512M+11.0%461M+10.0%419M-2.9%431M+21.5%355M+23.1%
Inventory479M+11.6%430M+2.1%421M-10.6%471M+27.1%370M+27.8%
Other current assets62.1M-18.6%76.3M+20.3%63.4M+14.4%55.4M-42.2%95.8M+98.3%
6.93B+2.7%6.75B+15.0%5.87B+6.4%5.51B+12.1%4.92B+11.4%
Property, plant & equipment468M+1.7%460M+7.0%430M+12.6%382M+16.7%327M+9.7%
Operating lease right-of-use120M-4.4%125M+5.8%118M+7.5%110M+2.6%107M+0.6%
Goodwill3.41B+5.0%3.25B+14.6%2.84B+7.6%2.64B+21.7%2.17B+14.4%
Intangible assets1.25B-2.9%1.28B+27.0%1.01B+6.8%948M+58.7%597M+43.7%
Deferred tax assets1.20M-20.0%1.50M+0.0%1.50M-25.0%2.00M-53.5%4.30M+72.0%
Other non-current assets154M-1.2%156M+12.4%139M-4.2%145M-1.6%147M-0.5%
575M-8.6%630M+25.9%500M-8.0%544M+13.3%480M+20.3%
Accounts payable225M+13.6%198M+10.1%180M-14.0%209M+16.8%179M+17.6%
Accrued liabilities297M+6.6%279M+2.7%272M-6.1%289M+11.3%260M+24.4%
Deferred revenue45.8M-9.7%50.7M-9.3%55.9M+25.1%44.7M-8.8%49.0M+72.5%
Short-term & current debt700K-99.3%101M+16683.3%600K0.000.00-100.0%
Current lease liability27.8M+6.5%26.1M+18.6%22.0M+1.9%21.6M+22.7%17.6M+5.4%
2.90B-1.7%2.95B+27.0%2.32B-6.0%2.47B+16.9%2.11B+12.8%
Long-term debt1.82B-2.1%1.86B+40.3%1.33B-9.8%1.47B+23.4%1.19B+14.0%
Deferred revenue (non-current)22.0M+66.7%13.2M-23.7%17.3M+15.3%15.0M-53.4%32.2M+5.9%
Non-current lease liability94.1M-7.4%102M+3.6%98.1M+1.6%96.6M+3.4%93.4M-1.0%
Operating lease liability (total)122M-4.5%128M+6.3%120M+1.6%118M+6.5%111M+0.0%
Deferred tax liabilities303M+13.4%267M-8.5%292M+10.5%264M+34.5%196M+19.8%
Other non-current liabilities202M+3.9%195M-5.8%207M+5.6%196M-20.9%247M-7.3%
4.03B+6.1%3.79B+7.2%3.54B+16.5%3.04B+8.4%2.80B+10.3%
Preferred stock0.000.000.000.000.00
Common stock900K+0.0%900K+0.0%900K+0.0%900K+0.0%900K+0.0%
Additional paid-in capital892M+3.2%865M+3.1%839M+2.7%817M+2.7%796M+2.6%
Retained earnings4.50B+6.4%4.23B+7.5%3.93B+11.4%3.53B+13.0%3.13B+10.0%
Treasury stock1.42B+21.6%1.17B-1.4%1.19B+0.2%1.18B+12.8%1.05B-1.3%
Accumulated other comprehensive income57.6M+144.0%-131M-185.8%-45.8M+63.7%-126M-81.3%-69.6M-415.6%
Non-controlling interest-1.30M-116.7%-600K-200.0%-200K-166.7%300K0.00-100.0%
Total equity incl. non-controlling4.03B+6.1%3.79B+7.1%3.54B+16.5%3.04B+8.4%2.80B+10.3%
Total liabilities & equity6.93B+2.7%6.75B+15.0%5.87B+6.4%5.51B+12.1%4.92B+11.4%
Common shares issued90.1M+0.0%90.1M+0.0%90.1M+0.0%90.1M-0.0%90.1M-0.0%
Common shares outstanding74.6M-1.7%75.9M+0.1%75.8M+0.2%75.6M-0.8%76.2M+0.3%
Shares outstanding (cover)74.3M-1.9%75.8M+0.2%75.6M+0.2%75.5M-0.8%76.1M+0.3%
Treasury shares15.5M+9.2%14.2M-0.7%14.3M-1.0%14.5M+4.2%13.9M-1.7%
Cash Flowas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
680M+1.8%668M-6.8%717M+28.6%557M-1.4%565M-0.7%
Depreciation & amortization207M+17.6%176M+15.5%152M+27.1%120M+16.2%103M+23.4%
Intangible amortization131M+22.0%107M+12.9%94.9M+37.5%69.0M+22.3%56.4M+34.9%
Share-based compensation27.3M+5.8%25.8M+18.3%21.8M+0.9%21.6M+5.9%20.4M+37.8%
Deferred income taxes12.8M+166.0%-19.4M-32.0%-14.7M+20.5%-18.5M-203.3%-6.10M-174.4%
Change in inventory34.2M+294.3%-17.6M+73.4%-66.2M-191.4%72.4M+57.0%46.1M+226.3%
-138M+86.3%-1.01B-254.7%-284M+69.1%-917M-31.4%-698M-304.5%
Capital expenditure63.6M-2.3%65.1M-27.6%89.9M+32.2%68.0M-6.5%72.7M+40.9%
Free cash flow617M+2.3%603M-3.8%627M+28.1%489M-0.6%493M-4.8%
Acquisitions76.2M-92.3%985M+215.7%312M-67.0%946M+63.8%577M+369.0%
Proceeds from sale of PP&E———8.90M0.00
Other investing activities-2.20M-133.8%6.50M+285.7%-3.50M+52.1%-7.30M-360.7%2.80M+233.3%
-633M-235.8%466M+235.2%-345M-811.9%-37.8M-297.9%-9.50M+77.7%
Long-term debt issued0.00-100.0%497M+396.7%100M-50.0%200M-60.0%499M+0.1%
Long-term debt repaid100M+100.0%50.0M-80.0%250M0.00-100.0%350M+16.5%
Common stock issued———0.000.00
Common stock repurchased248M0.00-100.0%24.2M-83.7%148M0.00-100.0%
Dividends paid213M+3.6%205M+7.7%191M+7.5%177M+10.1%161M+6.1%
Other financing activities-800K+66.7%-2.40M-84.6%-1.30M+27.8%-1.80M+60.9%-4.60M
FX effect on cash36.8M+260.7%-22.9M-244.0%15.9M+157.6%-27.6M+2.1%-28.2M-171.9%
Net change in cash-53.0M-150.7%105M+0.5%104M+124.5%-425M-149.4%-171M-143.4%
Interest paid72.2M+52.3%47.4M-6.7%50.8M+36.9%37.1M+3.1%36.0M+2.3%
Income taxes paid135M-21.5%171M-14.1%200M+13.6%176M+48.6%118M+35.6%
Valuation Ratiosas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Market cap13.3B-16.4%15.9B-3.3%16.4B-4.7%17.2B-4.4%18.0B+19.0%
P/E27.5×-12.7%31.5×+18.3%26.6×-11.1%29.9×-25.3%40.1×+0.0%
P/S3.8×-21.0%4.9×-2.5%5.0×-10.7%5.6×-14.3%6.5×+1.2%
P/B3.3×-21.3%4.2×-13.6%4.8×-21.1%6.1×-4.4%6.4×+7.8%
P/FCF21.5×-18.3%26.3×-4.6%27.6×-23.4%36.0×-1.4%36.6×+25.1%
Earnings yield3.6%+14.5%3.2%-15.5%3.8%+12.5%3.3%+33.9%2.5%-0.0%
FCF yield4.6%+22.4%3.8%+4.8%3.6%+30.5%2.8%+1.5%2.7%-20.0%
Dividend yield1.6%+21.0%1.3%+11.8%1.2%+12.2%1.1%+15.0%0.91%-9.0%
Source filing10-K10-K10-K10-K10-K
Fiscal yearCEOTotal, as reportedActually paidOther executives, average$100 in the stock$100 in peers
FY2025Mr Ashleman$9.1M$3M$1.6M$95.00$191.00
FY2024Mr Ashleman$9.4M$2.8M$1.7M$110.00$170.00
FY2023Mr Ashleman$7.8M$2.1M$1.8M$113.00$149.00
FY2022Mr Ashleman$7.5M$11.4M$2.4M$117.00$114.00
FY2021Mr Ashleman$6.7M$9.8M$1.7M$120.00$128.00
FY2020Mr. Ashleman $3.4M / $6MMr. Silvernail $8.9M / −$14.8M$12.3M−$8.9M$1.7M——

From the pay-versus-performance table of each proxy statement (DEF 14A), the newest that states the year. “Actually paid” values stock awards at the year’s closing price, so it falls when the stock does. A year two chief executives shared lists each one’s pay, as reported / actually paid, and the totals are both. $100 in the stock and in the peer group the proxy names are the newest proxy’s, from the start of its first year.

About this data

Source: IEX’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all IEX filings on SEC EDGAR → Not investment advice.